1. Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡. (13th September 2018) Authors: Conte, P; Frassoldati, A; Bisagni, G; Brandes, A A; Donadio, M; Garrone, O; Piacentini, F; Cavanna, L; Giotta, F; Aieta, M; Gebbia, V; Molino, A; Musolino, A; Ferro, A; Maltoni, R; Danese, S; Zamagni, C; Rimanti, A; Cagossi, K; Russo, A Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P11.26.A STAT3 expression in brain metastases from breast cancer: correlations with different molecular subtypes and clinical outcome. (5th September 2022) Authors: Pellerino, A; Bruno, F; Mo, F; Bertero, L; Bellini, E; Beano, A; Montemurro, F; Valiente, M; Rudà, R; Soffietti, R Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗